TipRanks
Go Ultimate55% OFF

Mazahir Alimohamed Profile - Oppenheimer Analyst

11 Followers

Mazahir Alimohamed's Stock Coverage

BBOT
BridgeBio Oncology Therapeutics
Oct 20, 2026BUYReiterated$16.004Ratings0%-47.47%
TARS
Tarsus Pharmaceuticals
Oct 02, 2026BUYReiterated$100.004Ratings100%+14.23%
TYRA
Tyra Bioscience
Sep 22, 2026BUYReiterated$40.003Ratings0%-26.30%
CNTB
Connect Biopharma Holdings
Sep 22, 2026BUYAssigned$5.002Ratings0%-51.85%
IRLA
IRulya Therapeutics
Aug 17, 2026BUYReiterated$82.002Ratings50%+23.15%
IKT
Inhibikase Therapeutics
Aug 12, 2026BUYReiterated$5.002Ratings0%-21.00%
IFRX
InflaRx
Jul 20, 2026BUYReiterated$9.003Ratings33%-7.47%
EWTX
Edgewise Therapeutics
Jul 09, 2026BUYInitiated$51.001Ratings0%-19.50%

Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.

Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Mazahir Alimohamed activity FAQ

What is the performance of Mazahir Alimohamed's recommendations?
The percentage of profitable recommendations made by Mazahir Alimohamed is 26.32%, and the average return per transaction is -16.80%.
What stocks does Mazahir Alimohamed cover?
What was Mazahir Alimohamed's most profitable rating?
Mazahir Alimohamed’s most profitable rating was a buy on IRulya Therapeutics stock on Jul 29, 2026. The return on the trade was 49.70%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here